Hua Jian Medical has partnered with Renhe International to jointly establish a vertical OTC drug-focused RWA transaction platform.

BlockBeats News, September 16th. Hong Kong Stock Exchange-listed company Concord Medical announced that the group has reached a strategic cooperation with Renhe International, an indirectly wholly-owned subsidiary of Renhe Pharmaceutical Co., Ltd., to jointly establish the world's first global vertical RWA transaction platform dedicated to the over-the-counter pharmaceutical sector in the United States.